UNSW to lead new drug trial for rare blood cancer
UNSW Sydney researchers will conduct a clinical trial to establish the safety and efficacy of…
Browsing: Rare Cancers
The fight goes on: Clinical trial shows promising new treatment for rare blood cancer
Lymphoma is a type of blood cancer that develops from lymphocytes (a type of white…
Molecular imaging offers insight into therapy outcomes for neuroendocrine tumour patients
A new proof-of-concept study published in the May issue of The Journal of Nuclear Medicine has demonstrated…
Gene signature found for poor response to standard chemotherapy in rare uterine cancer
Women who don’t survive a rare and aggressive uterine cancer called uterine serous carcinoma, have…
Eye and the scalpel: Ocular tumours easier to diagnose noninvasively
Australia is the sunniest continent on Earth—which is why it also has the highest rates…
Stem cells and nerves interact in tissue regeneration and cancer progression
Stem cells can generate a variety of specific tissues and are increasingly used for clinical…
Genetic insights into osteosarcoma in children unveiled
A study by researchers at the National Cancer Institute (NCI), part of the National Institutes…
Pembrolizumab shows promise for some advanced, hard-to-treat rare cancers
A study conducted by researchers at The University of Texas MD Anderson Cancer Center, USA,…
Immunotherapy combo effective for patients with high-grade neuroendocrine cancer
Many patients with rare, fast-growing neuroendocrine tumours respond well to a common immunotherapy drug combination,…
Osteosarcoma profiling reveals why immunotherapy remains ineffective
Comprehensive profiling of tumour samples taken from patients with shows that multiple factors contribute to…